Evidence map›Paper›PMID 36933117›Full record

SynthesisAnnals of nuclear medicine2023

Brown tumors in nuclear medicine: a systematic review.

Nicolas Jacquet-Francillon, Nathalie Prevot

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Annals of nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Case Report:Frontiers in nuclear medicine · 2025
    Article
  5. Use of bone-SPECT/CT and Na[Frontiers in nuclear medicine · 2025
    Review
  6. Endocrinology application of molecular imaging: current role of PET/CT.Journal of endocrinological investigation · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nicolas Jacquet-FrancillonNuclear Medicine Department, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Hopital Lyon Sud, 165 Chemin du Grand Revoyet, 69495, Pierre-Bénite, France. nicolas.jacquetfrancillon@gmail.com.ORCID http://orcid.org/0000-0003-4765-5322
Nathalie PrevotDepartment of Nuclear Medicine, University Hospital of Saint-Etienne, Saint-Étienne, France.
Inserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brown tumors (BT) are abnormal bone-repair processes and a consequence of hyperparathyroidism. The diagnosis of these lytic lesions in nuclear medicine, while a challenge, is not so rare, because functional imaging is used both in the management of cancer and hyperparathyroidism. The main objective of this review is to summarize the knowledge and the evidence concerning BT and the different imaging modalities in nuclear medicine. A systematic review was performed in Embase, PubMed and Google Scholar from 2005 to 2022. We included articles describing BT in the following imaging modalities: [

Indexed as

Hyperparathyroidism, PrimaryNuclear MedicineCholineFluorodeoxyglucose F18Gallium RadioisotopesHumansPositron Emission Tomography Computed TomographyRadionuclide ImagingSodium FluorideTechnetium Tc 99m SestamibiCholinefluorocholineFluorodeoxyglucose F18fluoromethylcholineGallium RadioisotopesSodium FluorideTechnetium Tc 99m SestamibiBrown tumorHyperparathyroidismPET/CTScintigraphySUV

Identifiers

PMID36933117
OpenAlexW4327811511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.